tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Edwards Lifesciences Advances with SAPIEN X4 Heart Valve Study
PremiumCompany AnnouncementsEdwards Lifesciences Advances with SAPIEN X4 Heart Valve Study
8d ago
Hold Rating for Edwards Lifesciences Amid Uncertainty in JenaValve Deal and Adjusted EPS Guidance
Premium
Ratings
Hold Rating for Edwards Lifesciences Amid Uncertainty in JenaValve Deal and Adjusted EPS Guidance
14d ago
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment
Premium
Company Announcements
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment
14d ago
Edwards Lifesciences raises FY25 adjusted EPS view to high-end of $2.45-$2.55
PremiumThe FlyEdwards Lifesciences raises FY25 adjusted EPS view to high-end of $2.45-$2.55
15d ago
Edwards to pursue regulatory approval after FTC action to block JenaValve deal
Premium
The Fly
Edwards to pursue regulatory approval after FTC action to block JenaValve deal
15d ago
Edwards Lifesciences’ SAPIEN 3 Valve Study: A Real-World Evaluation
Premium
Company Announcements
Edwards Lifesciences’ SAPIEN 3 Valve Study: A Real-World Evaluation
20d ago
Edwards Lifesciences upgraded to Buy from Neutral at BTIG
PremiumThe FlyEdwards Lifesciences upgraded to Buy from Neutral at BTIG
24d ago
Edwards Lifesciences upgraded to Outperform from Neutral at Daiwa
Premium
The Fly
Edwards Lifesciences upgraded to Outperform from Neutral at Daiwa
24d ago
Edwards Lifesciences Reports Strong Growth and Raises Guidance
Premium
Company Announcements
Edwards Lifesciences Reports Strong Growth and Raises Guidance
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100